BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36346459)

  • 21. Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience.
    Jeong SI; Kim W; Yu HW; Choi JY; Ahn CH; Moon JH; Choi SI; Cha W; Jeong WJ; Park SY; Na HY
    Endocr Pathol; 2023 Sep; 34(3):287-297. PubMed ID: 37515661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases.
    Xu B; David J; Dogan S; Landa I; Katabi N; Saliba M; Khimraj A; Sherman EJ; Tuttle RM; Tallini G; Ganly I; Fagin JA; Ghossein RA
    Histopathology; 2022 Jan; 80(2):322-337. PubMed ID: 34449926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
    Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
    Thyroid; 2019 Sep; 29(9):1255-1261. PubMed ID: 31397224
    [No Abstract]   [Full Text] [Related]  

  • 25. Poorly differentiated thyroid cancer.
    Patel KN; Shaha AR
    Curr Opin Otolaryngol Head Neck Surg; 2014 Apr; 22(2):121-6. PubMed ID: 24492853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
    Landa I; Ibrahimpasic T; Boucai L; Sinha R; Knauf JA; Shah RH; Dogan S; Ricarte-Filho JC; Krishnamoorthy GP; Xu B; Schultz N; Berger MF; Sander C; Taylor BS; Ghossein R; Ganly I; Fagin JA
    J Clin Invest; 2016 Mar; 126(3):1052-66. PubMed ID: 26878173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
    Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
    Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.
    Corver WE; Ruano D; Weijers K; den Hartog WC; van Nieuwenhuizen MP; de Miranda N; van Eijk R; Middeldorp A; Jordanova ES; Oosting J; Kapiteijn E; Hovens G; Smit J; van Wezel T; Morreau H
    PLoS One; 2012; 7(6):e38287. PubMed ID: 22675538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.
    Xu B; Reznik E; Tuttle RM; Knauf J; Fagin JA; Katabi N; Dogan S; Aleynick N; Seshan V; Middha S; Enepekides D; Casadei GP; Solaroli E; Tallini G; Ghossein R; Ganly I
    Endocrine; 2019 Apr; 64(1):97-108. PubMed ID: 30689169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.
    Wei S; LiVolsi VA; Montone KT; Morrissette JJ; Baloch ZW
    Endocr Pathol; 2015 Dec; 26(4):365-9. PubMed ID: 26530486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
    Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
    Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.
    Xu B; Ghossein R
    Endocr Pathol; 2016 Sep; 27(3):205-12. PubMed ID: 27372303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic and Molecular Features of Metastatic Follicular Thyroid Carcinoma in Patients Presenting With a Thyroid Nodule Versus a Distant Metastasis.
    Cracolici V; Kadri S; Ritterhouse LL; Segal JP; Wanjari P; Cipriani NA
    Am J Surg Pathol; 2019 Apr; 43(4):514-522. PubMed ID: 30557173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonanaplastic follicular cell-derived thyroid carcinoma: mitosis and necrosis in long-term follow-up.
    Skansing DB; Londero SC; Asschenfeldt P; Larsen SR; Godballe C
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2541-2548. PubMed ID: 28293786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of molecular testing on detecting mimics of oncocytic neoplasms in thyroid fine-needle aspirates diagnosed as follicular neoplasm of Hürthle cell (oncocytic) type.
    Landau MS; Nikiforov YE; Ohori NP; Chiosea SI
    Cancer Cytopathol; 2021 Oct; 129(10):788-797. PubMed ID: 33901345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma.
    Penna GC; Pestana A; Cameselle JM; Momesso D; de Andrade FA; Vidal APA; Araujo Junior ML; Melo M; Fernandes PV; Corbo R; Vaisman M; Sobrinho-Simões M; Soares P; Vaisman F
    Endocrine; 2018 Sep; 61(3):489-498. PubMed ID: 29948935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
    Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
    Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].
    Stratmann M; Sekulla C; Dralle H; Brauckhoff M
    Chirurg; 2012 Jul; 83(7):646-51. PubMed ID: 22273853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.